Exodus Point Capital Management, LP Pulmonx Corp Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Pulmonx Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 75,246 shares of LUNG stock, worth $486,089. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,246
Previous 48,552
54.98%
Holding current value
$486,089
Previous $308,000
102.6%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding LUNG
# of Institutions
124Shares Held
31MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.68MShares$36.7 Million0.04% of portfolio
-
Morgan Stanley New York, NY3.79MShares$24.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$14.7 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$7.76 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $241M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...